Company Overview
About Insilico Medicine
Insilico Medicine is a clinical-stage biotechnology company founded in 2014 that leverages generative AI for drug discovery and development. Headquartered in Boston with offices in Hong Kong and New York, the company has built AI platforms utilizing deep generative models, reinforcement learning, and transformers to discover novel drug targets and generate molecular structures with desired properties. Its pipeline spans cancer, fibrosis, CNS diseases, infectious diseases, autoimmune conditions, and aging-related diseases.
Business Model & Competitive Advantage
The company operates a dual business model combining internal drug pipeline development with external platform licensing and partnerships. Insilico has secured major collaboration deals valued at billions of dollars with partners including Eli Lilly, Sanofi, Fosun Pharma, Exelixis, and Menarini. Its competitive edge lies in an end-to-end AI platform covering target discovery through clinical candidate nomination, significantly compressing traditional drug development timelines and costs.
Competitive Landscape 2025–2026
Insilico listed on the Hong Kong Stock Exchange on December 30, 2025, in the largest biotech IPO on HKEX that year, raising $293M. In March 2026, the company signed a landmark $2.75B agreement with Eli Lilly including a $115M upfront payment. Total 2025 revenue reached $56.2M. With over $393M in cash post-IPO and a robust partnership portfolio valued at over $3.5B collectively, Insilico is positioned as a leading AI-native pharma company.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Insilico Medicine is an established challenger with significant market presence and competitive offerings in Healthcare Tech.
Growth Stage
Insilico Medicine has achieved $293M in revenue, demonstrating strong product-market fit.
Frequently Asked Questions
Compare Insilico Medicine with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Start Comparison →Claim This Profile
Are you from Insilico Medicine? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Insilico Medicine Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Insilico Medicine vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →